Literature DB >> 27251881

Linker design for the modular assembly of multifunctional and targeted platinum(ii)-containing anticancer agents.

S Ding1, U Bierbach2.   

Abstract

A versatile and efficient modular synthetic platform was developed for assembling multifunctional conjugates and targeted forms of platinum-(benz)acridines, a class of highly cytotoxic DNA-targeted hybrid agents. The synthetic strategy involved amide coupling between succinyl ester-modified platinum compounds (P1, P2) and a set of 11 biologically relevant primary and secondary amines (N1-N11). To demonstrate the feasibility and versatility of the approach, a structurally and functionally diverse range of amines was introduced. These include biologically active molecules, such as rucaparib (a PARP inhibitor), E/Z-endoxifen (an estrogen receptor antagonist), and a quinazoline-based tyrosine kinase inhibitor. Micro-scale reactions in Eppendorf tubes or on 96-well plates were used to screen for optimal coupling conditions in DMF solution with carbodiimide-, uronium-, and phosphonium-based compounds, as well as other common coupling reagents. Reactions with the phosphonium-based coupling reagent PyBOP produced the highest yields and gave the cleanest conversions. Furthermore, it was demonstrated that the chemistry can also be performed in aqueous media and is amenable to parallel synthesis based on multiple consecutive reactions in DMF in a "one-tube" format. In-line LC-MS was used to assess the stability of the conjugates in physiologically relevant buffers. Hydrolysis of the conjugates occurs at the ester moiety and is facilitated by the aquated metal moiety under low-chloride ion conditions. The rate of ester cleavage greatly depends on the nature of the amine component. Potential applications of the linker technology are discussed.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27251881      PMCID: PMC4987242          DOI: 10.1039/c6dt01399f

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  36 in total

Review 1.  Mitochondrial biology, targets, and drug delivery.

Authors:  Lara Milane; Malav Trivedi; Amit Singh; Meghna Talekar; Mansoor Amiji
Journal:  J Control Release       Date:  2015-04-01       Impact factor: 9.776

Review 2.  Platinum formulations as anticancer drugs clinical and pre-clinical studies.

Authors:  Nicholas P Farrell
Journal:  Curr Top Med Chem       Date:  2011       Impact factor: 3.295

Review 3.  The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.

Authors:  Timothy C Johnstone; Kogularamanan Suntharalingam; Stephen J Lippard
Journal:  Chem Rev       Date:  2016-02-11       Impact factor: 60.622

4.  Characterization of recombinant human carboxylesterases: fluorescein diacetate as a probe substrate for human carboxylesterase 2.

Authors:  Jie Wang; Eric T Williams; Joanne Bourgea; Y Nancy Wong; Christopher J Patten
Journal:  Drug Metab Dispos       Date:  2011-05-03       Impact factor: 3.922

Review 5.  Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.

Authors:  Alina Shapira; Yoav D Livney; Henk J Broxterman; Yehuda G Assaraf
Journal:  Drug Resist Updat       Date:  2011-02-16       Impact factor: 18.500

Review 6.  Targeting epidermal growth factor receptor: central signaling kinase in lung cancer.

Authors:  Takeshi Yoshida; Guolin Zhang; Eric B Haura
Journal:  Biochem Pharmacol       Date:  2010-05-24       Impact factor: 5.858

Review 7.  Molecular mechanisms of cisplatin resistance.

Authors:  L Galluzzi; L Senovilla; I Vitale; J Michels; I Martins; O Kepp; M Castedo; G Kroemer
Journal:  Oncogene       Date:  2011-09-05       Impact factor: 9.867

8.  DNA metalating-intercalating hybrid agents for the treatment of chemoresistant cancers.

Authors:  Jimmy Suryadi; Ulrich Bierbach
Journal:  Chemistry       Date:  2012-09-17       Impact factor: 5.236

Review 9.  The resurgence of platinum-based cancer chemotherapy.

Authors:  Lloyd Kelland
Journal:  Nat Rev Cancer       Date:  2007-07-12       Impact factor: 60.716

10.  Redesigning the DNA-targeted chromophore in platinum-acridine anticancer agents: a structure-activity relationship study.

Authors:  Amanda J Pickard; Fang Liu; Thomas F Bartenstein; Laura G Haines; Keith E Levine; Gregory L Kucera; Ulrich Bierbach
Journal:  Chemistry       Date:  2014-10-10       Impact factor: 5.236

View more
  1 in total

1.  Evaluation of a Platinum-Acridine Anticancer Agent and Its Liposomal Formulation in an in vivo Model of Lung Adenocarcinoma.

Authors:  Song Ding; Christopher L Hackett; Fang Liu; Ryan G Hackett; Ulrich Bierbach
Journal:  ChemMedChem       Date:  2020-10-22       Impact factor: 3.466

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.